drugset / Trial / NCT00102167

Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)

NCT00102167

Phase 3 Completed 663 enrolled H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to evaluate the safety and effectiveness of Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia for insomnia (a sleep disorder).

Timeline

Start
2005-02
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject gaboxadol Small molecule 10 mg
Subject gaboxadol Small molecule 15 mg

Indications